When looking at cognitive impairment in schizophrenia, there are several clear challenges:
- Identifying patients who would benefit from treatment
- Determining if a new treatment for cognition impairment is successful
- Assessing multiple cognitive domains without overburdening patients
- The impact of fluctuating symptoms
Join this expert panel to discuss these highlighted challenges and offer solutions to scientific research in this space.
Topics will include:
- Patient screening and stratification: patients presenting with similar symptoms and severity are identified and grouped together to enable better data analysis
- Accurate and efficient assessment of multiple cognitive domains: simplifying and improving the patient experience to increase participant retention
- Case study: The Potential Role of the M1/M4 Muscarinic Receptor Agonist KarXT in the Treatment of Cognitive Impairment in Patients With Schizophrenia